Skip to content

Strategies for Perioperative Infection Prevention and Accelerated Rehabilitation Management in Spinal Surgery

Efficacy and safety of perioperative sequential administration of tranexamic acid combined with chewing gum in reducing blood loss and improving gastrointestinal dysfunction after PLIF

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096980
Enrollment
Unknown
Registered
2025-02-10
Start date
2025-02-10
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopedic related diseases

Interventions

"Tranexamic acid combined with chewing gum" group:Chew gum for 20-30 minutes at 8:00, 12:00 and 18:00 every day before surgery and the first three days after surgery, respectively
Tranexamic acid was injected intravenously at 5h, 10h and 15h, respectively
The "chewing gum" group:Chew gum for 20-30 minutes at 8:00, 12:00 and 18:00 every day before surgery and the first three days after surgery respectively
Tranexamic acid group:Tranexamic acid was injected intravenously at 5h, 10h and 15h, respectively
Control group:Normal saline was injected intravenously at 5h, 10h and 15h after operation

Sponsors

Chongqing Orthopedic Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Patients admitted to our hospital were diagnosed with lumbar degenerative diseases (lumbar disc herniation, lumbar spinal stenosis, lumbar spondylolisthesis); 2) Volunteer to participate in the study and sign the informed consent; 3) Hemoglobin (Hb) and coagulation function were normal before operation; 4) Color ultrasound of both lower limbs showed no abnormality.

Exclusion criteria

Exclusion criteria: 1) All patients with no such diagnosis were excluded from the study; 2) Preoperative anemia (Hb: female 1.4, or activated partial thrombin time (APTT) >1.4 times the normal value; 7) Serious heart, lung, liver, renal insufficiency.

Design outcomes

Primary

MeasureTime frame
Gastrointestinal function indicators (first defecation, exhaust, bowel sound recovery time, constipation, abdominal distension, nausea, vomiting,oral comfort, etc.);Liver and kidney function (prealbumin, total protein, Alb, ALT, AST, BUN, Cr ,etc.);Inflammatory response related indicators;Drainage tube removal time, postoperative bed rest time to ambulation time, etc.;Postoperative complication(exudation, hematoma, infection, etc.);Postoperative wound drainage volume, HCT of postoperative wound drainage fluid;Pain-related parameter indicators;Blood loss related parameters (total blood loss,postoperative blood loss, dominant blood loss, hidden blood loss, intraoperative blood loss, drainage fluid blood content, etc.);Bood routine(HCTHbRBC;PLT);The incidence of thrombosis ( deep vein thrombosis, muscular calf vein thrombosis, pulmonary embolism, myocardial infarction, etc.);

Secondary

MeasureTime frame
Basic demographic parameters ( age, gender, height, weight, etc.);Length of stay ( total length of stay, preoperative length of stay, postoperative length of stay, etc.);Medical expenses;Duration of operation (min), length of incision (cm);Anesthesia related parameters ( ASA classification, cardiopulmonary function classification, Mallampati classification, etc.);Clinical diagnosis, past history, osteoporosis, etc.;Chalybeate, EPO, anti-inflammatory and analgesic drugs and other drugs use and follow-up.;Coagulation and fibrinolysis indexes(PTINRAPTTTTFIBFDPD-D);Coagulation factors(????????);Thrombelastogram(TEG);

Countries

China

Contacts

Public ContactWei Dong

Chongqing Orthopedic Hospital of Traditional Chinese Medicine

dongweibwcx@163.com+86 159 2254 4701

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026